Liminal BioSciences
Liminal is a biotechnology company that develops novel small molecule compounds to treat respiratory, liver and renal diseases.
Business Model:
Revenue: $628
Employees: 201-500
Rankings
Industries / Tags:
Detailed Liminal BioSciences Information
Geographic Data
Address: 440 Armand-Frappier Blvd.
City: Laval
State: quebec
Zip: H7V 4B4
Country: CA
Financial Info
Stage:
post ipo equity
Raised Last:
$37M
Raised Total:$127M
Social
Metrics
9,341,297Website Global Rank
256Website Monthly Traffic
Twitter Followers
Description
Liminal is a biotechnology company that develops novel small molecule compounds to treat respiratory, liver and renal diseases.
Contact Phone:
Contact Email:
Liminal BioSciences went public on 11/18/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
11/18/2019
Ticker Symbol:
LMNL
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2017 | Debt | $80M | 2/2016 | Debt | $22.2M | 3/2017 | Debt | $25M | 3/2016 | Post-IPO Debt | 2 | $30M |
Jefferies Thomvest Ventures Thomvest Ventures Jefferies Thomvest Ventures Thomvest Ventures |
8/2014 | Post-IPO Equity | 1 | $20M |
Thomvest Ventures Thomvest Ventures Thomvest Ventures Thomvest Ventures |
5/2016 | Private Equity Round | 7 | $46.1M |
National Bank Financial Beacon Securities Scotiabank RBC Capital Markets Paradigm Capital CIBC World Markets Canaccord Genuity Group Canaccord Genuity Group RBC Capital Markets National Bank Financial Beacon Securities Scotiabank RBC Capital Markets Paradigm Capital CIBC World Markets Canaccord Genuity Group Canaccord Genuity Group RBC Capital Markets |
6/2019 | Post-IPO Equity | $37.1M | 4/2017 | Post-IPO Equity | $9.5M | 11/2013 | Post-IPO Equity | $5.1M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2020 | Fairhaven Pharmaceuticals | |
| 8/2016 | Telesta Therapeutics | |
| 9/2008 | Pathogen Removal and Diagnostic Technologies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
